CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

What drives time-to-randomization in oncology trials?

Neutral
AI Analysis

Summary

Analysis of factors affecting time-to-randomization in oncology trials, including screen failures, biomarker delays, eligibility criteria, and patient dropouts.

Importance:1/10
Sentiment:
0.00
oncologyclinical trialstime-to-randomizationtrial operations

Read the original article

Published by Clinical Trials Arena on September 22, 2026 10:58 AM

Read Original